好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy and Safety of Idebenone in a 6-Month US Phase 3 Clinical Study of Idebenone in Children with Friedreich's Ataxia
Movement Disorders
(-)
180
Authors/Disclosures
David R. Lynch, MD, PhD (Children's Hospital of Philadelphia) The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Susan L. Perlman, MD (UCLA) Dr. Perlman has nothing to disclose.
William T. Andrews, MD No disclosure on file
Anand V. Patel, MD (University of Texas Medical Branch) Dr. Patel has nothing to disclose.
Prachaya Srivanitchapoom, MD No disclosure on file
Thomas Meier, PhD (Santhera Pharmaceuticals) No disclosure on file